NORMS FOR RAJIV GANDHI EQUITY SCHEME THIS WEEK
NEW DELHI: In yet another reform measure to deepen capital markets and
attract retail investors into equities, the government is set to notify
norms for the Rajiv Gandhi Equity Savings Scheme (RGESS) in the coming
week.
Government sources said the finance ministry will define the rules of the tax saving scheme with mutual funds likely to be given access with a set of riders.
The scheme, announced in this year’s budget but not yet notified,
is a first- of-its-kind which allows the retail investor to invest up to
R50, 000 directly into equity shares and avai tax benefit on 50% of the
investment.
Government sources said the finance ministry will define the rules of the tax saving scheme with mutual funds likely to be given access with a set of riders.
The investor, however should have income of less than R10 lakhs in a year. The benefits will be made available only to first time investors in equity markets and will come bundled with a lock-in period of three years.
Sources said the government has come around to the view that it is more prudent to allow investors to route their savings to the scheme through mutua funds, rather than exposing to the risks of capital market volatility. “The mutual funds that will be allowed to access to the scheme will have to fulfil a set of condi tions,” said a source, who did not wish to be identified.
“Only those funds that invest in blue chips such as BSE 100 and
CNX 100 companies wil initially be allowed to route investments to the
scheme,” said the source. A minor tweak ing in the lock-in period norms
are also expected, the source said.
Market regulator Securities and Exchange Board of India (SEBI) has also made a strong pitch for allowing asset man agement companies to create products specifically tailored for the scheme.
Market regulator Securities and Exchange Board of India (SEBI) has also made a strong pitch for allowing asset man agement companies to create products specifically tailored for the scheme.
No comments:
Post a Comment